Terumo Cardiovascular and CytoSorbents collaborate to commercialize CytoSorb in ten U.S. hotspot states under emergency use authorization for COVID-19

Terumo Cardiovascular and CytoSorbents collaborate to commercialize CytoSorb in US. (Credit: FreeDigitalPhotos.net/dream designs.)



Related Article
Recommended Whitepaper

View More